A model that selectively expresses mutant tau in one of the first brain regions known to be affected in AD, such as the entorhinal cortex [102], would allow for a better understanding of the role of glutamate dysregulation in the spread of pathological tau. Here, MAPT is linked to Alzheimer disease.